Medicine and Dentistry
Radiation Therapy
100%
Neoplasm
76%
Brain Metastasis
61%
Brachytherapy
54%
Hyperthermia
48%
Whole Brain Radiotherapy
34%
Efaproxiral
34%
Implant
32%
Stereotactic Radiosurgery
28%
Overall Survival
26%
Nodular Melanoma
25%
Bone Marrow Transplantation
25%
Lymphedema
25%
Pediatrics
25%
Cyclophosphamide
24%
Malignant Neoplasm
21%
Bendamustine
19%
External Beam Radiotherapy
19%
Treatment Planning
19%
Glioblastoma
19%
Brain Tumor
18%
Hematologic Malignancy
17%
Radiosensitivity
17%
Oncology
17%
Radiosurgery
17%
Medulloblastoma
17%
Non Melanoma Skin Cancer
17%
Involved-Field Radiotherapy
17%
Limb
16%
Disease
15%
Adenocarcinoma
14%
Transplantation
14%
Breast Cancer
13%
Surgery
13%
Recurrent Disease
13%
Disease Exacerbation
13%
Hindlimb
13%
Skin Cancer
12%
Biological Marker
12%
Clinical Trial
12%
T Cell
12%
Interstitial Brachytherapy
11%
Arm
11%
Choroid Melanoma
11%
In Vitro
10%
Metastatic Carcinoma
10%
Stereotactic Radiation Therapy
10%
Epidermal Growth Factor Receptor
10%
Non Small Cell Lung Cancer
10%
Transrectal Ultrasonography
9%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
59%
Hyperthermia
39%
Brain Metastasis
34%
Efaproxiral
34%
Glioblastoma
25%
Malignant Neoplasm
21%
Non Small Cell Lung Cancer
20%
Recurrent Disease
19%
Epidermal Growth Factor Receptor
19%
Ionizing Radiation
17%
Pteridine Derivative
17%
Cyclophosphamide
15%
Breast Cancer
14%
Pterin
13%
Disease
13%
Bendamustine
11%
Overall Survival
10%
Glioma
9%
Phase II Trials
9%
Metastasis
9%
Hematologic Malignancy
9%
Clinical Trial
8%
Integrin
8%
Protein Tyrosine Kinase Inhibitor
8%
Nuclear Protein
8%
Cosmetics
8%
Skin Cancer
8%
Prostate Carcinoma
8%
Rindopepimut
8%
Amuvatinib
8%
Neck Injury
8%
Erlotinib
8%
Gefitinib
8%
Non Melanoma Skin Cancer
8%
Prostate Cancer
8%
B Cell Lymphoma
8%
Protein Tyrosine Kinase
8%
Rituximab
8%
Osteosarcoma
8%
Ibritumomab Tiuxetan
8%
Biological Marker
8%
Progression Free Survival
7%
Prostate Specific Antigen
7%
Recurrence Free Survival
7%
Adenocarcinoma
6%
Tumor Recurrence
5%
Remission
5%
Fludarabine
5%
Squamous Cell Carcinoma
5%
Deoxyribonucleoprotein
5%
Keyphrases
Tumor
25%
Stereotactic Radiosurgery
21%
Thermoradiotherapy
18%
Electronic Brachytherapy
17%
Radiation Therapy
17%
Focused Ultrasound Hyperthermia
17%
Ferromagnetic Implant
15%
Radiosurgery
14%
Hyperthermia
14%
Interstitial Hyperthermia
12%
Melanoma Brain Metastases
12%
Brain Metastases
12%
Whole Brain Radiation Therapy
12%
Cancer Treatment
11%
Hyperthermia Treatment
11%
Interstitial Brachytherapy
11%
Treatment Planning
10%
Linear Accelerator (LINAC)
10%
Radiotherapy
10%
Locoregional Control
9%
Template-guided
8%
Pelvic Sarcoma
8%
Post-transplantation Cyclophosphamide (PTCy)
8%
Episcleral Plaque
8%
Iodine-125 Brachytherapy
8%
Orbital Pseudotumor
8%
Hippocampal Avoidance
8%
Orbital Lymphoma
8%
Caeruloplasmin
8%
Small Cell Osteosarcoma
8%
Arizona
8%
Hypofractionated Radiotherapy
8%
Fractionation Regimen
8%
Recurrent Medulloblastoma
8%
Fractionated Stereotactic Radiotherapy
8%
Implant Procedure
8%
Primary T-cell Lymphoma
8%
Cellular Radiosensitivity
8%
Vulvar Squamous Cell Carcinoma
8%
Targeted Radiotherapy
8%
Stereotaxic
8%
Radioimaging
8%
Brachytherapy Boost
8%
Ultrasound Hyperthermia
8%
CT-based
8%
Clinical Experience
8%
Focussed Ultrasound
8%
Pediatric
8%
Lower Uterine Segment
8%
Vaginal Cuff
8%
